Phase I studies

Phase I Clinical Trial Outsourcing & Market Trends

Early-phase trials require a delicate balance of speed and safety. As more biotechs enter the clinic, Phase I CROs are being scrutinized for their recruitment capabilities and healthy volunteer databases. ISR’s Phase I research focuses on the selection criteria for early-phase partners, analyzing how “First-in-Human” expertise and clinic-to-lab integration influence sponsor preference.